|
Volumn 9, Issue 2, 1996, Pages 120-123
|
0.05% clobetasol 17-propionate cream and ointment but not the corresponding 0.1 % triamcinolone acetonide preparations increase skin surface roughness: A possible dissociation of unwanted epidermal and dermal effects
a a a a |
Author keywords
Eczema craquel ; Skin roughness; Topical glucocorticoids
|
Indexed keywords
CLOBETASOL PROPIONATE;
TRIAMCINOLONE ACETONIDE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DERMIS;
DOUBLE BLIND PROCEDURE;
ECZEMA;
EPIDERMIS;
HUMAN;
HUMAN EXPERIMENT;
NORMAL HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SKIN ABRASION;
SKIN SURFACE;
SKIN TOXICITY;
SKINFOLD THICKNESS;
TOPICAL DRUG ADMINISTRATION;
ULTRASOUND;
ADMINISTRATION, TOPICAL;
ANTI-INFLAMMATORY AGENTS;
CLOBETASOL;
DERMATITIS, IRRITANT;
DOSAGE FORMS;
DOUBLE-BLIND METHOD;
FEMALE;
FOREARM;
GLUCOCORTICOIDS;
HUMANS;
MALE;
OINTMENTS;
SKIN;
TRIAMCINOLONE ACETONIDE;
|
EID: 0029920348
PISSN: 16605527
EISSN: 16605535
Source Type: Journal
DOI: 10.1159/000211407 Document Type: Article |
Times cited : (4)
|
References (7)
|